Michael Seckler
Amministratore Delegato presso EVOME MEDICAL TECHNOLOGIES INC.
Patrimonio netto: - $ in data 31/05/2024
Posizioni attive di Michael Seckler
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| EVOME MEDICAL TECHNOLOGIES INC. | Direttore/Membro del Consiglio | 13/06/2023 | - |
| Amministratore Delegato | 13/06/2023 | - | |
GLyPharma Therapeutic, Inc.
 GLyPharma Therapeutic, Inc. BiotechnologyHealth Technology GLyPharma Therapeutic, Inc. develops oncology therapeutic treatment. It engages in the development of the clinical efficacy of FE 203799, a novel proprietary Glucagon-Like Peptide-2(GLP-2) analogue exerting unique pharmacological effects in a first-in-class, meaningful indication for patients with hematological malignancies receiving myelotoxic therapies. The company was founded in August 2012 and is headquartered in Montreal, Canada. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Michael Seckler
Precedenti posizioni note di Michael Seckler
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
FerGene, Inc.
 FerGene, Inc. BiotechnologyHealth Technology FerGene, Inc. provides gene therapy solutions to urologists. The company is headquartered in Cambridge, MA. | Direttore operativo | 01/10/2022 | 01/05/2023 |
| Corporate Officer/Principal | 01/01/2020 | 01/10/2022 | |
Ferring Pharmaceuticals, Inc.
 Ferring Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ferring Pharmaceuticals, Inc. develops and markets fertility and endocrinology products. Its products include Bravelle, Repronex, Novarel, Acthrel and Desmopressin Acetate. The company's products are used in treatment of osteoarthritis, prostate cancer, and other infertility related diseases. Ferring Pharmaceuticals was founded in 1951 and is headquartered in Parsippany, NJ. | Vendite & Marketing | 01/03/2003 | 01/12/2019 |
Formazione di Michael Seckler
| The Pennsylvania State University | Masters Business Admin |
Statistiche
Distribuzione geografica
| Stati Uniti | 5 |
| Canada | 2 |
Posizioni
| Director/Board Member | 2 |
| Sales & Marketing | 1 |
| Chief Executive Officer | 1 |
Settori
| Health Technology | 5 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| EVOME MEDICAL TECHNOLOGIES INC. | Health Technology |
| Aziende private | 3 |
|---|---|
Ferring Pharmaceuticals, Inc.
Ferring Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ferring Pharmaceuticals, Inc. develops and markets fertility and endocrinology products. Its products include Bravelle, Repronex, Novarel, Acthrel and Desmopressin Acetate. The company's products are used in treatment of osteoarthritis, prostate cancer, and other infertility related diseases. Ferring Pharmaceuticals was founded in 1951 and is headquartered in Parsippany, NJ. | Health Technology |
GLyPharma Therapeutic, Inc.
GLyPharma Therapeutic, Inc. BiotechnologyHealth Technology GLyPharma Therapeutic, Inc. develops oncology therapeutic treatment. It engages in the development of the clinical efficacy of FE 203799, a novel proprietary Glucagon-Like Peptide-2(GLP-2) analogue exerting unique pharmacological effects in a first-in-class, meaningful indication for patients with hematological malignancies receiving myelotoxic therapies. The company was founded in August 2012 and is headquartered in Montreal, Canada. | Health Technology |
FerGene, Inc.
FerGene, Inc. BiotechnologyHealth Technology FerGene, Inc. provides gene therapy solutions to urologists. The company is headquartered in Cambridge, MA. | Health Technology |
- Borsa valori
- Insiders
- Michael Seckler
- Esperienza
